314
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Patterns of psychological distress related to regular methamphetamine and opioid use

, , , &
Pages 121-127 | Received 03 Nov 2009, Accepted 10 Feb 2010, Published online: 12 Jan 2011

References

  • Borges G, Walters EE, Kessler RC. Associations of substance use, abuse, and dependence with subsequent suicidal behaviour. American Journal of Epidemiology 2000; 151: 781–789
  • Brienza RS, Stein MD, Chen MH, Cogineni A, Sobota M, Maksad J, Clark J. Depression among needle exchange and methadone maintenance clients. Journal of Substance Abuse Treatment 2000; 18: 331–337
  • Clark HW, Masson CL, Delucchi KL, Hall SM, Sees KL. Violent traumatic events and drug abuse severity. Journal of Substance Abuse Treatment 2001; 20: 121–127
  • Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 2006; 67: 247–257
  • Curran C, Byrappa N, McBride A. Stimulant psychosis: Systematic review. British Journal of Psychiatry 2004; 185: 196–204
  • Dalmau A, Bergman B, Brismar B. Psychotic disorders among in-patients with abuse of cannabis, amphetamines and opiates. Do dopaminergic stimulants facilitate psychiatric illness?. European Psychiatry 1999; 14: 366–371
  • Darke S, Kaye S, McKetin R, Duflou J. The major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 2008; 27: 253–262
  • Darke S, Mills KL, Ross J, Teesson M, Williamson A, Havard A. Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatric Research 2009; 166: 7–14
  • Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 1997; 48: 135–141
  • Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence 2004; 74: 77–83
  • Dean A, Bell J, Christie MJ, Mattick RP. Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence. European Psychiatry 2004; 19: 510–513
  • Derogatis LR. BSI, Brief Symptom Inventory: Administration, scoring, and procedures manual, 4th. National Computer Systems, Minneapolis 1993
  • Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviours among injection drug users in and out of treatment. Drug and Alcohol Dependence 1996; 43: 1–11
  • Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Taylor C. Psychosis and drug dependence: Results from a national survey of prisoners. British Journal of Psychiatry 2002; 181: 393–398
  • Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study (UK). Addictive Behaviors 2002; 27: 155–166
  • Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996; 91: 81–87
  • Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviours 1997; 11: 261–278
  • Jackson CT, Covell NH, Frisman LK, Essock SM. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. Journal of Dual Diagnosis 2004; 1: 49–63
  • Kiddorf M, Brooner RK, King VL, Chutuape MA, Stitzer ML. Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. Drug and Alcohol Dependence 1996; 42: 117–123
  • Matsumoto T, Kamijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, Kosaka K. Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction 2002; 97: 809–817
  • McKetin R, McLaren J, Lubman D, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473–1478
  • Mills K, Lynskey M, Teesson M, Ross J, Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence and correlates. Drug and Alcohol Dependence 2005; 77: 243–249
  • Nakama H, Chang L, Cloak C, Jiang C, Alicata D, Haning W. Association between psychiatric symptoms and craving in methamphetamine users. American Journal on Addictions 2008; 17: 441–446
  • Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review 2005; 24: 411–418
  • Rossow I, Lauritzen G. Shattered childhood: A key issue in suicidal behavior among drug addicts. Addiction 2001; 96: 227–240
  • SPSS Inc. (2006). SPSS for Windows, 15.0. Chicago: SPSS Inc.
  • Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. Journal of Nervous and Mental Disease 1991; 179: 215–221
  • United Nations Office of Drug Control (2008). World illicit drug report 2008. New York: United Nations Publications.
  • Welp EA, Bosman I, Langedam MW, Totte M, Maes RA, Van Ameijden EJ. Amount of self-reported illicit drug use compared to quantitative hair test results in community-recruited young drug users in Amsterdam. Addiction 2003; 98: 987–994
  • World Health Organization (1997). Composite international diagnostic interview (version 2.1). Vienna: World Health Organization.
  • Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M. Psychiatric symptoms in methamphetamine users. American Journal on Addictions 2004; 13: 181–190

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.